Desacetylmethylcolchicine in Acute Gouty Arthritis
- 27 October 1955
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 253 (17) , 730-732
- https://doi.org/10.1056/nejm195510272531706
Abstract
COLCHICINE has been the drug of choice for the treatment of patients with attacks of acute gouty arthritis because it usually causes prompt and effective symptomatic relief.1 , 2 Despite its dramatic, favorable effect in ameliorating the symptoms of this acute arthritis, it may cause gastrointestinal disturbances such as nausea, vomiting and diarrhea, or a combination of these symptoms, which are so severe in some patients as to prevent its use.Recent investigations with derivatives of colchicine have shown that although these compounds may retain potent antimitotic activity they produce less systemic toxicity in normal and tumor-bearing mice.3 4 5 6 A natural alkaloid, differing . . .Keywords
This publication has 12 references indexed in Scilit:
- Desacetylmethylcolchicine in Treatment of Myeloid LeukaemiaBMJ, 1955
- Effects of Phenylbutazone in GoutNew England Journal of Medicine, 1954
- Butazolidin in the Treatment of Gout: With a Comparison with Other AgentsMedical Clinics of North America, 1954
- Die Wirkung von Demecolceinamiden an Zellenin vitroCellular and Molecular Life Sciences, 1954
- Demecolcin (Substanz F), ein neues, aus Colchicum autumnale isoliertes Alkaloid mit starker antimitotischer WirkungKlinische Wochenschrift, 1954
- Gout—Its Diagnosis and TreatmentPostgraduate Medicine, 1953
- Colchicine. Derivatives of Trimethylcolchicinic Acid1,2Journal of the American Chemical Society, 1953
- Colchicinwirkungen und GranulocytopoeseJournal of Molecular Medicine, 1953
- Current principles of management in goutThe American Journal of Medicine, 1952
- Studies on colchicine derivatives.I. Toxicity in mice and effects on mouse sarcoma 180Cancer, 1950